Home Tools
Log in
Cart

AD80

Catalog No. T4301   CAS 1384071-99-1

AD80, a multikinase inhibitor, inhibits RET, RAF, SRCand S6K, with greatly reduced mTOR activity.

All products from TargetMol are for Research Use Only. Not for Human or Veterinary or Therapeutic Use.
AD80 Chemical Structure
AD80, CAS 1384071-99-1
Pack Size Availability Price/USD Quantity
1 mg In stock $ 39.00
5 mg In stock $ 93.00
10 mg In stock $ 148.00
25 mg In stock $ 297.00
50 mg In stock $ 488.00
100 mg In stock $ 716.00
500 mg In stock $ 1,480.00
1 mL * 10 mM (in DMSO) In stock $ 97.00
Bulk Inquiry
Get quote
Select Batch  
Purity: 100%
Purity: 99.9%
Contact us for more batch information
Biological Description
Chemical Properties
Storage & Solubility Information
Description AD80, a multikinase inhibitor, inhibits RET, RAF, SRCand S6K, with greatly reduced mTOR activity.
Targets&IC50 RET (V804M):0.4 nM, RET (V804L):0.6 nM
In vitro AD80 and AD81 effectively inhibit key signaling molecules (RET, RAF, SRC, S6K) with significantly diminished mTOR activity compared to AD57 and AD58. Specifically, AD80 stands out for its proficient inhibition of the Ras–Erk pathway, showcasing a well-balanced polypharmacological profile that targets Ret, Raf, Src, Tor, and S6K, yielding high efficacy with minimal toxicity. Furthermore, AD80 demonstrates potent anti-proliferative effects on MZ-CRC-1 and TT thyroid cancer cells in vitro, likely mediated by triggering apoptosis. Additionally, AD80 uniquely suppresses S6K1 in conjunction with inhibiting the TAM family tyrosine kinase AXL, preventing S6K1 phosphorylation and its association with mTOR. This leads to a sustained inhibition of S6K1-driven signaling and protein synthesis, underscoring its therapeutic potential.
In vivo AD80 significantly improves survival rates, rescuing 50% of mice transplanted with PTEN-deficient leukemia cells. When administered orally, both AD80 and AD81 remarkably allow 70-90% of Drosophila ptc>dRetMEN2B model animals to reach adulthood, surpassing the effectiveness of AD57. Furthermore, AD80 demonstrates superior tumor growth inhibition and minimizes body-weight fluctuations compared to vandetanib in a mouse xenograft model.
Cell Research MZ-CRC-1 (MEN2B) and TT (MEN2A) cells are treated with AD80 (0.2 nM to 20 μM) for 7 days and cell viability is quantitated by MTT assay.
Animal Research Mice showing established growing tumors are separated into vehicle or drug treatment groups. A similar range of tumor sizes is selected for each experiment (vehicle vs AD57; vehicle vs AD80 vs Vandetanib). Vehicle, AD57 (20 mg/kg), AD80 (30 mg/kg), or Vandetanib (50 mg/kg) are administered by oral gavage (PO; per os or by mouth) once daily, five times a week. Tumor and body weight measurements are performed 3 times a week.
Molecular Weight 473.43
Formula C22H19F4N7O
CAS No. 1384071-99-1

Storage

Powder: -20°C for 3 years | In solvent: -80°C for 1 year

Solubility Information

DMSO: 150 mg/mL

TargetMolReferences and Literature

1. Dar AC, et al. Chemical genetic discovery of targets and anti-targets for cancer polypharmacology.Nature. 2012 Jun 6;486(7401):80-4. 2. Liu H, et al. Pharmacologic Targeting of S6K1 in PTEN-Deficient Neoplasia.Cell Rep. 2017 Feb 28;18(9):2088-2095. 3. Carlos J A E G, Lima K, Costa-Lotufo L V, et al. AD80, a multikinase inhibitor, exhibits antineoplastic effects in acute leukemia cellular models targeting the PI3K/STMN1 axis[J]. Investigational New Drugs. 2021: 1-11.

TargetMolCitations

1. de Almeida L C, Carlos J A E G, Rezende-Teixeira P, et al. AD80, a multikinase inhibitor, as a potential drug candidate for colorectal cancer therapy. Life Sciences. 2022: 120911. 2. Carlos J A E G, Lima K, Costa-Lotufo L V, et al. AD80, a multikinase inhibitor, exhibits antineoplastic effects in acute leukemia cellular models targeting the PI3K/STMN1 axis. Investigational New Drugs. 2021 Aug;39(4):1139-1149. doi: 10.1007/s10637-021-01066-w. Epub 2021 Jan 21. 3. Carlos J A E G, Lima K, Costa-Lotufo L V, et al. AD80, a multikinase inhibitor, exhibits antineoplastic effects in acute leukemia cellular models targeting the PI3K/STMN1 axis. Investigational New Drugs. 2021 Aug;39(4):1139-1149. doi: 10.1007/s10637-021-01066-w. Epub 2021 Jan 21. 4. Lima K, de Miranda L B L, Del Milagro Bernabe Garnique A, et al.The Multikinase Inhibitor AD80 Induces Mitotic Catastrophe and Autophagy in Pancreatic Cancer Cells.Cancers.2023, 15(15): 3866.

Related compound libraries

This product is contained In the following compound libraries:
Inhibitor Library Tyrosine Kinase Inhibitor Library Anti-Ovarian Cancer Compound Library NO PAINS Compound Library Antidepressant Compound Library Anti-Breast Cancer Compound Library Bioactive Compounds Library Max Kinase Inhibitor Library Glycolysis Compound Library Anti-Pancreatic Cancer Compound Library

Related Products

Related compounds with same targets
Effusanin A Regorafenib Cyclorasin 9A5 Sorafenib-d3 B-Raf IN 16 Griffipavixanthone I-37 TAK-632

TargetMolDose Conversion

You can also refer to dose conversion for different animals. More

TargetMol In vivo Formulation Calculator (Clear solution)

Step One: Enter information below
Dosage
mg/kg
Average weight of animals
g
Dosing volume per animal
ul
Number of animals
Step Two: Enter the in vivo formulation
% DMSO
%
% Tween 80
% ddH2O
Calculate Reset

TargetMolCalculator

Molarity Calculator
Dilution Calculator
Reconstitution Calculation
Molecular Weight Calculator
=
X
X

Molarity Calculator allows you to calculate the

  • Mass of a compound required to prepare a solution of known volume and concentration
  • Volume of solution required to dissolve a compound of known mass to a desired concentration
  • Concentration of a solution resulting from a known mass of compound in a specific volume
See Example

An example of a molarity calculation using the molarity calculator
What is the mass of compound required to make a 10 mM stock solution in 10 ml of water given that the molecular weight of the compound is 197.13 g/mol?
Enter 197.13 into the Molecular Weight (MW) box
Enter 10 into the Concentration box and select the correct unit (millimolar)
Enter 10 into the Volume box and select the correct unit (milliliter)
Press calculate
The answer of 19.713 mg appears in the Mass box

X
=
X

Calculator the dilution required to prepare a stock solution

Calculate the dilution required to prepare a stock solution
The dilution calculator is a useful tool which allows you to calculate how to dilute a stock solution of known concentration. Enter C1, C2 & V2 to calculate V1.

See Example

An example of a dilution calculation using the Tocris dilution calculator
What volume of a given 10 mM stock solution is required to make 20ml of a 50 μM solution?
Using the equation C1V1 = C2V2, where C1=10 mM, C2=50 μM, V2=20 ml and V1 is the unknown:
Enter 10 into the Concentration (start) box and select the correct unit (millimolar)
Enter 50 into the Concentration (final) box and select the correct unit (micromolar)
Enter 20 into the Volume (final) box and select the correct unit (milliliter)
Press calculate
The answer of 100 microliter (0.1 ml) appears in the Volume (start) box

=
/

Calculate the volume of solvent required to reconstitute your vial.

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial.
Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

g/mol

Enter the chemical formula of a compound to calculate its molar mass and elemental composition

Tip: Chemical formula is case sensitive: C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:
To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.
Definitions of molecular mass, molecular weight, molar mass and molar weight:
Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed n the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

bottom

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.

Keywords

AD80 1384071-99-1 Angiogenesis Apoptosis MAPK PI3K/Akt/mTOR signaling Tyrosine Kinase/Adaptors Raf c-RET Src S6 Kinase AD 80 Inhibitor inhibit Raf kinases AD-80 Ribosomal S6 Kinase (RSK) S6K RET inhibitor

 

TargetMol